scalability

R&D

The impact of generative AI on protein design for drug disco...

Artificial Intelligence (AI) is at the heart of the latest global transformation, not least within the biopharmaceutical industry.

Digital

embracing AI illustration of man on hand

Biopharma’s AI rally: Readiness not hype in 2025

The drumbeat of AI advancements over the last year has left us all breathless, wondering which benchmark will be broken next and which new problems we can solve in biology.

Digital

Scaling AI in life sciences: From automation to strategic tr...

When talking about AI in pharma and life sciences marketing, we often focus on the automation of content creation, management, and delivery.

Digital

Turning pilots into production: How to create, scale, and su...

Pharmaceutical companies are eagerly pursuing GenAI products and use cases to generate value within their organisations.

R&D

A greener catalysis: Talking sustainable, scalable chemistry...

As King’s College London (KCL) scientists are once more in the headlines – this time with new ‘plug and play’ drug delivery technology that could offer a

Digital